Avoid long-term continuous therapy; contact w/ eyes; applying on the breast. Limit therapy to no more than 14 days at a time to minimise risk of developing resistance. May be associated w/ increased susceptibility to infection, aggravation of existing infection, & activation of latent infection. Contains butyl hydroxyanisole, cetyl alcohol & K sorbate. Pregnancy. Childn. Fusidic acid: Reports of bacterial resistance. Hydrocortisone acetate: Always consider possible systemic absorption during treatment. Risk of reversible hypothalamic-pituitary-adrenal (HPA) axis suppression following systemic absorption.